
Dr. Lal Pathlabs (LALPATHLAB) Share Price Falls 2.34% as Large Cap Healthcare Stock Declines
Updated: 15 Oct 2026 • 10:51 am
Posted by:

Dr. Lal Pathlabs Share Price moved lower today, with the stock trading at Rs 1,891.55, down 2.34%, and the company carrying a market capitalisation of Rs 32,084.3 crore. The move placed Dr. Lal Pathlabs Share Price in focus as a large cap healthcare name, especially after the stock opened at Rs 1,939.65 and traded between Rs 1,939.65 and Rs 1,891.55 during the morning trade. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes Dr. Lal Pathlabs Share Price news a numbers-led story today: a clear share price fall, a high valuation profile, and a position that still sits well above the sector median on both profitability and pricing metrics. Investors tracking Dr. Lal Pathlabs Share Price today are therefore looking at the same set of measurable facts that define the stock’s near-term setup.
For readers following Dr. Lal Pathlabs Share Price live, the key point is that the decline is intraday and visible in the gap between the previous close of Rs 1,936.9 and the current quote. Univest data shows the stock also touched its day low at Rs 1,891.55, which is the same level as the current trade, so the latest print reflects the weakest point seen so far in the morning session.
Dr. Lal Pathlabs (LALPATHLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,891.55 |
| Previous Close | Rs 1,936.9 |
| Today's Move | -Rs 45.35 (-2.34%) |
| Open | Rs 1,939.65 |
| High | Rs 1,939.65 |
| Low | Rs 1,891.55 |
| Market Capitalisation | Rs 32,084.3 crore |
| Market Cap Category | Large Cap |
Dr. Lal Pathlabs Share Price today opened above the previous close, but the stock quickly moved lower and stayed near the day’s low. The opening price was Rs 1,939.65, the day high was also Rs 1,939.65, and the day low was Rs 1,891.55. Against the previous close of Rs 1,936.9, the stock was down Rs 45.35, or 2.34%, at Rs 1,891.55. This keeps Dr. Lal Pathlabs Share Price in the red while the session is still open, and the move is enough to make the stock stand out in Dr. Lal Pathlabs Stock News coverage for the day. The company remains a Large Cap with market capitalisation of Rs 32,084.3 crore, so the decline is being watched in the context of a sizeable listed healthcare business rather than a small, thinly followed company. In Dr. Lal Pathlabs Share Price terms, today’s action is straightforward: an early high was not sustained, and the stock is now trading at the session low. That sets up the next question around valuation and fundamentals.
Dr. Lal Pathlabs (LALPATHLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 32,084.3 crore |
| P/E Ratio | 59.99x |
| P/B Ratio | 12.44x |
| ROE | 22.37% |
| ROCE | 29.56% |
| EPS | Rs 32.29 |
| Book Value Per Share | Rs 155.67 |
| Dividend Yield | 1.06% |
Dr. Lal Pathlabs (LALPATHLAB) fundamental metrics show P/E 59.99x, P/B 12.44x, ROE 22.37%, ROCE 29.56%. These ratios show where the company stands today and are not a call to buy or sell.
Dr. Lal Pathlabs has a market capitalisation of Rs 32,084.30 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.99x, P/B at 12.44x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.37% and ROCE of 29.56%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 32.29, book value per share of Rs 155.67, dividend yield of 1.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.53x, median ROE of 12.95%, median ROCE of 15.83%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 59.99x |
| Benchmark Median P/E | 42.53x |
| Benchmark Average P/E | 93.66x |
| Benchmark P/E Range | 6.89x to 1,519.52x |
| Company P/B Ratio | 12.44x |
| Benchmark Median P/B | 3.66x |
| Benchmark Average P/B | 4.04x |
| Company ROE | 22.37% |
| Benchmark Median ROE | 12.95% |
| Benchmark Average ROE | 11.24% |
| Company ROCE | 29.56% |
| Benchmark Median ROCE | 15.83% |
| Benchmark Average ROCE | 2.2% |
| Company Market Capitalisation | Rs 32,084.3 crore |
| Benchmark Median Market Cap | Rs 519.19 crore |
| Benchmark Average Market Cap | Rs 10,148.77 crore |
Dr. Lal Pathlabs (LALPATHLAB) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Dr. Lal Pathlabs (LALPATHLAB) has a P/E ratio of 59.99x, which is above the benchmark median of 42.53x, a difference of +41.05%. A P/E difference of this kind is a reference point rather than a recommendation.
Dr. Lal Pathlabs (LALPATHLAB) has a ROE of 22.37%, which is above the benchmark median of 12.95%, a difference of +72.74%. Dr. Lal Pathlabs (LALPATHLAB) has a ROCE of 29.56%, which is above the benchmark median of 15.83%, a difference of +86.73%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,13,201.66 | 53.74 | 11.59 | 23.54 | 21.73 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 87,860.62 | 95.81 | 5.15 | 12.95 | 13.93 |
| Max Healthcare Institute | MAXHEALTH | 84,035.61 | 56.99 | 7.6 | 14.53 | 14.97 |
| Aster DM Healthcare | ASTERDM | 60,058.23 | 184.74 | 13.92 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 57,074.84 | 53.99 | 5.57 | 11.32 | 14.07 |
Dr. Lal Pathlabs (LALPATHLAB) has a P/E ratio of 59.99x compared with the displayed peer median of 56.99x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.37% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 29.56% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Dr. Lal Pathlabs (LALPATHLAB) has a market capitalisation of Rs 32,084.3 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Dr. Lal Pathlabs
- Dr. Lal Pathlabs Share Price is down 2.34% today, making the morning move visible in Dr. Lal Pathlabs Share Price Today coverage.
- The stock traded from Rs 1,939.65 to Rs 1,891.55, with the current print at the day low.
- Large Cap status keeps Dr. Lal Pathlabs Share Price relevant in healthcare stock analysis and market cap comparisons.
- P/E of 59.99 and P/B of 12.44 keep valuation central to Dr. Lal Pathlabs Fundamental Analysis.
- ROE of 22.37% and ROCE of 29.56% show strong return ratios versus the same-industry benchmark.
About Dr. Lal Pathlabs
Dr. Lal Pathlabs operates in Healthcare, specifically the Hospital & Healthcare Services industry. The company is known for diagnostic and pathology-led healthcare services and is positioned as a large listed business within its segment. Its market capitalisation of Rs 32,084.3 crore places Dr. Lal Pathlabs Share Price in the Large Cap category, which is materially above the industry median market capitalisation in the benchmark set. The company’s valuation and return ratios suggest a business that the market prices at a premium relative to many healthcare peers. For investors reading Dr. Lal Pathlabs Share Price news, the core business context remains important: this is a healthcare services company with strong profitability metrics and a premium market position.
Track Dr. Lal Pathlabs Share Price on Univest
Use Dr. Lal Pathlabs (LALPATHLAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Dr. Lal Pathlabs Share Price on Univest for live updates, valuation ratios, market capitalisation, 52-week levels and company insights in one place. Univest also helps readers follow Dr. Lal Pathlabs Stock News, peer comparison and sector context without switching between multiple pages. For anyone monitoring Dr. Lal Pathlabs Share Price Today, this creates a quick way to review the latest trade, fundamentals and market position as new information appears.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Dr. Lal Pathlabs Share Price fall today?
Ans. Dr. Lal Pathlabs Share Price fell 2.34% to Rs 1,891.55 in morning trade. The price move is confirmed in Univest data; a company-specific reason has not been established. The stock also touched its day low at the current price.
What is Dr. Lal Pathlabs Share Price today?
Ans. Dr. Lal Pathlabs Share Price was at Rs 1,891.55, down Rs 45.35 from the previous close of Rs 1,936.9. The stock opened at Rs 1,939.65 and moved to the day low, showing a clear intraday decline.
Is Dr. Lal Pathlabs a Large Cap stock?
Ans. Yes. Dr. Lal Pathlabs is a Large Cap company with market capitalisation of Rs 32,084.3 crore. That size keeps Dr. Lal Pathlabs Share Price relevant for healthcare stock analysis and for comparison with other listed hospital and diagnostics names.
What is Dr. Lal Pathlabs Share Price valuation?
Ans. Dr. Lal Pathlabs Share Price is trading at a P/E of 59.99 and a P/B of 12.44. Those ratios are above the same-industry benchmark median, so the stock carries a premium valuation profile versus many healthcare peers.
How strong are Dr. Lal Pathlabs profitability ratios?
Ans. Dr. Lal Pathlabs reports ROE of 22.37% and ROCE of 29.56%, both above the same-industry benchmark median and average. These return ratios support the Dr. Lal Pathlabs Fundamental Analysis even when the Share Price moves lower.
What do EPS and book value show for Dr. Lal Pathlabs?
Ans. EPS is Rs 32.29 and book value is Rs 155.67 per share. EPS indicates earnings attributable to each share, while book value shows the accounting net worth behind each share at the current Dr. Lal Pathlabs Share Price.
Does Dr. Lal Pathlabs pay dividends?
Ans. The dividend yield is 1.06%, which reflects the historical payout relative to the current Dr. Lal Pathlabs Share Price. Investors often read this alongside valuation, because yield alone does not capture the full business quality or pricing profile.
How does Dr. Lal Pathlabs compare with healthcare peers?
Ans. Dr. Lal Pathlabs Share Price sits above several peers on P/E and P/B, while its ROE and ROCE are also stronger than many in the same industry set. Apollo Hospitals, Max Healthcare and Fortis provide useful valuation reference points.
Should investors track Dr. Lal Pathlabs Share Price today?
Ans. Investors may track Dr. Lal Pathlabs Share Price today because the stock combines a 2.34% decline with premium valuation, strong return ratios and a large market capitalisation. Univest can be used to follow price, ratios and sector context together.
Recent Articles

Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
19 November 2026

Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
19 November 2026

Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
19 November 2026

Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
HGS (INDIA) LIMITED Hits Upper Circuit on NSE, 19 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





